Litigation Details for AMAG PHARMACEUTICALS, INC. v. SANDOZ INC. (D.N.J. 2016)
✉ Email this page to a colleague
AMAG PHARMACEUTICALS, INC. v. SANDOZ INC. (D.N.J. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-03-17 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-03-26 |
| Cause | 35:271 Patent Infringement | Assigned To | Peter G. Sheridan |
| Jury Demand | None | Referred To | Lois H. Goodman |
| Patents | 6,599,498; 7,553,479; 7,871,597; 8,501,158; 8,591,864; 8,926,947 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in AMAG PHARMACEUTICALS, INC. v. SANDOZ INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for AMAG PHARMACEUTICALS, INC. v. SANDOZ INC. (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-03-08 | 131 | Text of Proposed Order | United States Patent Nos. 6,599,498 B1 (“the ’498 patent”), 7,553,479 B2 (“the ’479 patent”), 7,871,597…“the ’597 patent”), 8,591,864 B2 (“the ’864 patent”), and 8,926,947 B2 (“the ’947 patent”), which are…597, ’864 and ’947 patents; WHEREAS the ’479, ’597, ’864 and ’947 patents expire March 8, 2020…2020, and the ’498 patent expires June 30, 2023; …2016 26 March 2018 3:16-cv-01508 830 Patent None District Court, D. New Jersey | External link to document |
| 2017-04-11 | 62 | and Affirmative Defenses Related to U.S. Patent No. 8,501,158. (Attachments: # 1 Text of Proposed Order…2016 26 March 2018 3:16-cv-01508 830 Patent None District Court, D. New Jersey | External link to document | |
| 2017-04-11 | 63 | Counterclaims and Affirmative Defenses Related to US Patent No. 8,501,158. Signed by Judge Peter G. Sheridan on 4/…2016 26 March 2018 3:16-cv-01508 830 Patent None District Court, D. New Jersey | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
